Method of preventing, countering, or reducing NSAID-induced gastrointestinal damage by administering milk or egg products from hyperimmunized animals
July 30, 2016. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesMethod of treating inflammation using bovine milk Manufacture and use of fowl egg antibodies Method of treating protozoal gastrointestinal disorders by administering hyperimmune milk product Anti-cholesterolemic egg, vaccine and method for production, and use Anti-inflammatory factor, method of isolation, and use Large-scale purification of egg immunoglobulin Method for purifying egg yolk immunoglobulins Patent #: 5420253 InventorsAssigneeApplicationNo. 688576 filed on 07/30/1996US Classes:424/157.1, Derived from, or present in, food product (e.g., milk, colostrum, whey, eggs, etc.)424/158.1Binds hormone or other secreted growth regulatory factor, differentiation factor, or intercellular mediator (e.g., cytokine, vascular permeability factor, etc.); or binds serum protein, plasma protein, fibrin, or enzymeExaminersPrimary: Saucier, Sandra E.International ClassA61K 039/395AbstractA method of preventing, countering or reducing chronic gastrointestinal disorders or NSAID-induced gastrointestinal damage in a subject suffering from such ailments. The method comprises hyperimmunizing an egg-producing and/or milk-producing animal and administering an effective amount of hyperimmunized egg product, hyperimmunized milk product or mixtures thereof to the subject.Other References
Field of SearchDerived from, or present in, food product (e.g., milk, colostrum, whey, eggs, etc.)Binds hormone or other secreted growth regulatory factor, differentiation factor, or intercellular mediator (e.g., cytokine, vascular permeability factor, etc.); or binds serum protein, plasma protein, fibrin, or enzyme | |
